Urology treats urinary tract diseases in all genders and male reproductive issues, covering the kidneys, bladder, prostate, urethra, from infections to complex cancers.
Send us all your questions or requests, and our expert team will assist you.
The decision to proceed with a TURP is rarely driven by the size of the prostate alone but rather by the severity of the symptoms it causes. These symptoms, collectively termed Lower Urinary Tract Symptoms (LUTS), are the clinical manifestation of the hydrodynamic struggle between the bladder pump and the prostatic obstruction. They are categorized into two distinct phases: voiding (emptying) symptoms and storage (filling) symptoms.
Voiding symptoms are the direct mechanical result of the obstruction. Patients typically experience hesitancy, a delay in the initiation of urination as the bladder generates enough pressure to overcome the resistance. The urinary stream is often weak, thin, and lacks force. Intermittency, where the stream stops and starts, occurs as the bladder muscle fatigues mid-void. Straining to void is a compensatory mechanism where the patient recruits abdominal muscles to assist the bladder. Terminal dribbling, the prolonged leaking of urine at the end of voiding, is another classic sign of mechanical blockage.
Storage symptoms, conversely, are related to the bladder’s response to chronic obstruction. As the bladder muscle (detrusor) works harder, it undergoes hypertrophy (thickening) and neural remodeling. This leads to instability and hypersensitivity. Patients experience frequency, the need to urinate often, and urgency, a sudden, compelling desire to pass urine that is difficult to defer. Nocturia, waking multiple times at night to urinate, is one of the most bothersome symptoms, disrupting sleep architecture and quality of life. In severe cases, urge incontinence occurs when the bladder contracts involuntarily against the patient’s will. It is critical to understand that while TURP relieves the obstruction (voiding symptoms) immediately, the storage symptoms may take months to resolve as the bladder muscle regenerates and normalizes its neural signaling.
Without intervention, the natural history of BPH progresses through phases of compensation to decompensation. Initially, the bladder compensates for the obstruction by thickening its muscle wall. This allows it to generate higher pressures and maintain flow. During this phase, symptoms may be stable or slowly worsening.
However, cellular limits eventually are reached. The detrusor muscle fibers begin to be replaced by collagen deposits (fibrosis), reducing contractility. This is the phase of decompensation. The bladder becomes unable to empty, leading to the accumulation of residual urine. This chronic retention stretches the bladder wall further, thinning it out and rendering it atonic (weak). Symptoms may paradoxically change; the patient may no longer feel urgency but instead experience overflow incontinence, where the bladder is perpetually full and leaks simply because it cannot hold any more. This stage represents a failure of the physiological system and is a strong risk factor for needing surgical intervention like TURP to prevent permanent renal damage.
The primary risk factor for the development of symptoms necessitating TURP is age. BPH is a relentless, age-dependent process. Histological evidence of hyperplasia is present in the majority of men by age 60 and nearly all men by age 80. The cumulative exposure to androgens over a lifetime drives this growth.
Metabolic syndrome is an influential modern risk factor. Central obesity, insulin resistance, and dyslipidemia create a systemic inflammatory state. This inflammation affects the prostate, promoting cellular proliferation and fibrosis. Men with metabolic syndrome tend to have larger prostates and more severe LUTS compared to their lean counterparts.
Genetic predisposition also plays a role. Men with a family history of early-onset BPH requiring surgery are at a higher risk. This genetic component likely involves polymorphisms in the androgen receptor gene or genes regulating steroid metabolism.
Not all men with BPH need TURP. The risk factors that tip the scale toward surgery include the failure of medical therapy. Alpha-blockers (which relax the prostate) and 5-alpha reductase inhibitors (which shrink the prostate) are the first line of defense. When these drugs stop working, or if the side effects are intolerable, TURP becomes the next logical step.
Prostate size itself is a variable risk factor. While larger prostates generally cause more obstruction, small prostates can also be highly obstructive if the growth is strategic, such as a “median lobe” that grows directly into the bladder neck, forming a ball valve. This specific anatomical configuration is often resistant to medication and responds exceptionally well to TURP.
Understanding who is at risk for complications during or after TURP is vital for patient safety.
Chronic inflammation, often asymptomatic (histologic prostatitis), is a risk factor for both symptom severity and surgical difficulty. Inflammation increases blood flow to the prostate, which can lead to higher intraoperative bleeding. It also promotes fibrosis, making the gland more challenging to treat and potentially affecting the healing of the prostatic fossa post-surgery. Research suggests that targeting this inflammatory pathway may be key to future preventive strategies, but it currently remains a variable that surgeons must manage intra-operatively.
Send us all your questions or requests, and our expert team will assist you.
Nocturia, or waking up to pee, occurs because the bladder becomes irritated from working against the blockage. It sends “full” signals to the brain even when it contains only a small amount of urine. Additionally, the bladder may not empty during the day, leaving less room for the urine produced at night.
BPH is a progressive condition. While symptoms can fluctuate, the physical blockage generally does not improve on its own. Waiting too long can lead to the bladder muscle becoming permanently stretched and weak (decompensation), which might not be reversible even with surgery. Regular monitoring is essential if you choose to wait.
Surprisingly, no. A huge prostate might grow outward and cause few symptoms, while a very small prostate might grow inward or have a flap (median lobe) that blocks the opening completely. The shape and location of the growth matter more than the total volume.
Diabetes can damage the nerves that control the bladder (neuropathy). This creates a “double hit” scenario: the prostate blocks the flow, and the diabetic bladder cannot squeeze hard enough to overcome it. This combination increases the risk of urinary retention and makes recovery after surgery more complex.
The prostate has different zones. Sometimes, the middle part of the prostate (median lobe) grows upward into the bladder. It acts like a ball valve or a sink stopper. When you try to urinate, the flow of urine pushes this lobe down over the opening, abruptly blocking the flow. TURP is highly effective for this specific type of growth.
Men often worry that an enlarged prostate means they’re losing their vitality. But, modern TURP surgery brings good news: it’s very safe.At Liv Hospital, we use
Men with enlarged prostate symptoms need to pick the right treatment. Understanding modern treatments like the Green Light Laser Transurethral Resection of Prostate is key.Studies
Transurethral resection of the prostate (TURP) is the top choice for treating an enlarged prostate. At Liv Hospital, we know that TURP surgery is a big
Transurethral resection of the prostate (TURP) is a common treatment for BPH. This condition makes it hard to urinate because the prostate is too big.
Transurethral resection of the prostate (TURP) is a surgery to treat a common prostate issue. It removes extra prostate tissue that blocks urine flow. Knowing what
Leave your phone number and our medical team will call you back to discuss your healthcare needs and answer all your questions.
Your Comparison List (you must select at least 2 packages)
